{"id":"https://openalex.org/W3083323241","doi":"https://doi.org/10.1158/1538-7445.am2020-3415","title":"Abstract 3415: Mutant BRAF small molecule inhibition enhances oncolytic herpes virus immunotherapy through increased immune cell recruitment and activation in melanoma","display_name":"Abstract 3415: Mutant BRAF small molecule inhibition enhances oncolytic herpes virus immunotherapy through increased immune cell recruitment and activation in melanoma","publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3083323241","doi":"https://doi.org/10.1158/1538-7445.am2020-3415","mag":"3083323241"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-3415","doi":"https://doi.org/10.1158/1538-7445.am2020-3415","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-3415","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091759985","display_name":"Galabina Bozhanova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Galabina Bozhanova","raw_affiliation_strings":["1The Institute of Cancer Research, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The Institute of Cancer Research, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040654682","display_name":"Victoria A. Jennings","orcid":"https://orcid.org/0000-0003-1321-0333","observed_orcids":["https://orcid.org/0000-0003-1321-0333"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Victoria Jennings","raw_affiliation_strings":["1The Institute of Cancer Research, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The Institute of Cancer Research, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052909829","display_name":"Malin Pedersen","orcid":"https://orcid.org/0000-0003-1887-733X","observed_orcids":["https://orcid.org/0000-0003-1887-733X"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Malin Pedersen","raw_affiliation_strings":["1The Institute of Cancer Research, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The Institute of Cancer Research, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014211772","display_name":"Joan Kyula","orcid":"https://orcid.org/0000-0002-9299-0544","observed_orcids":["https://orcid.org/0000-0002-9299-0544"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Joan Kyula","raw_affiliation_strings":["1The Institute of Cancer Research, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The Institute of Cancer Research, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023782365","display_name":"Emmanuel Christian Patin","orcid":"https://orcid.org/0000-0001-5390-5733","observed_orcids":["https://orcid.org/0000-0001-5390-5733"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Emmanuel Patin","raw_affiliation_strings":["1The Institute of Cancer Research, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The Institute of Cancer Research, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081596429","display_name":"Jehanne Hassan","orcid":"https://orcid.org/0000-0003-3353-6605","observed_orcids":["https://orcid.org/0000-0003-3353-6605"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jehanne Hassan","raw_affiliation_strings":["1The Institute of Cancer Research, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The Institute of Cancer Research, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076318169","display_name":"Masahiro Ono","orcid":"https://orcid.org/0000-0002-9284-7326","observed_orcids":["https://orcid.org/0000-0002-9284-7326"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Masahiro Ono","raw_affiliation_strings":["2Imperial College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Imperial College London, London, United Kingdom","institution_ids":["https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072284989","display_name":"Kevin Joseph Harrington","orcid":"https://orcid.org/0000-0002-6014-348X","observed_orcids":["https://orcid.org/0000-0002-6014-348X"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kevin Harrington","raw_affiliation_strings":["1The Institute of Cancer Research, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The Institute of Cancer Research, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069116024","display_name":"Alan A. Melcher","orcid":"https://orcid.org/0000-0002-2042-3380","observed_orcids":["https://orcid.org/0000-0002-2042-3380"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alan Melcher","raw_affiliation_strings":["1The Institute of Cancer Research, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The Institute of Cancer Research, London, United Kingdom;","institution_ids":["https://openalex.org/I142947616"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"3415","last_page":"3415"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6625999808311462,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6625999808311462,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.16529999673366547,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.08889999985694885,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/braf-v600e-mutation","display_name":"BRAF V600E mutation","score":0.7609999775886536},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8299999833106995},{"id":"https://openalex.org/keywords/oncolytic-herpesvirus","display_name":"oncolytic herpesvirus","score":0.8169999718666077},{"id":"https://openalex.org/keywords/plx4720","display_name":"PLX4720","score":0.9950000047683716},{"id":"https://openalex.org/keywords/mapk-pathway-inhibitors","display_name":"MAPK pathway inhibitors","score":0.6629999876022339},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7910000085830688},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.6930000185966492},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.7429999709129333},{"id":"https://openalex.org/keywords/cytotoxic-cd8-t-cells","display_name":"CD8+ cytotoxic T lymphocytes","score":0.8579999804496765},{"id":"https://openalex.org/keywords/t-cell-receptor-activation","display_name":"T cell receptor stimulation","score":0.8209999799728394},{"id":"https://openalex.org/keywords/immune-cell-recruitment","display_name":"immune cell recruitment","score":0.7210000157356262},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.6140000224113464}],"concepts":[{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.8946884870529175},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.7105711698532104},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6653062701225281},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5575921535491943},{"id":"https://openalex.org/C2777877232","wikidata":"https://www.wikidata.org/wiki/Q17144704","display_name":"Immunogenic cell death","level":4,"score":0.5021297931671143},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.48321473598480225},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.42847979068756104},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.42075812816619873},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4034656286239624},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3904016315937042},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3796325922012329}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-3415","doi":"https://doi.org/10.1158/1538-7445.am2020-3415","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-3415","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8299999833106995}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2972226514","https://openalex.org/W2620207365","https://openalex.org/W2950977605","https://openalex.org/W2902626376","https://openalex.org/W4382699865","https://openalex.org/W4306391007","https://openalex.org/W4309717489","https://openalex.org/W3154696046","https://openalex.org/W3129646946","https://openalex.org/W4386209587"],"abstract_inverted_index":{"Abstract":[0],"Small":[1],"molecule":[2,317],"inhibitors":[3,52],"of":[4,24,33,46,69,85,120,171,183,204,229,236,258,270,273,292,336,340],"the":[5,21,67,83,138,142,176,230,255,268,337,341],"MAPK":[6],"pathway":[7],"have":[8,53,75],"demonstrated":[9],"rapid":[10],"responses":[11,74],"in":[12,107,137,149,164,186,239,276,331],"melanoma":[13,64,111,184,332],"patients,":[14],"but":[15,66],"their":[16,289],"use":[17],"is":[18],"hindered":[19],"by":[20,161],"frequent":[22],"development":[23],"acquired":[25],"resistance.":[26],"Oncolytic":[27],"viruses":[28,61],"are":[29,190,244,250],"a":[30,97,108,117,146,154,200,212],"novel":[31,201],"class":[32],"immunotherapeutics":[34],"which":[35,158,216],"selectively":[36],"replicate":[37],"inside":[38],"cancer":[39],"cells,":[40,65],"causing":[41],"lysis":[42],"and":[43,50,89,101,123,207,233,254,261,288,329,351],"subsequent":[44,234,262],"activation":[45,228,235,330],"anti-tumor":[47],"immunity.":[48],"BRAF":[49,315],"MEK":[51],"previously":[54],"been":[55,77],"shown":[56],"to":[57,62,96,116,145,175,180,224,279],"synergise":[58],"with":[59],"oncolytic":[60,91,320],"kill":[63],"consequences":[68],"these":[70],"interactions":[71],"on":[72,192],"immune":[73,237,247,326],"not":[76],"assessed.":[78],"Here,":[79],"we":[80,243],"show":[81],"that":[82,249],"combination":[84,114,143],"PLX4720":[86],"(BRAFV600E":[87],"inhibitor)":[88],"intratumoral":[90],"herpes":[92,321],"virus":[93,322],"HSV1716":[94],"led":[95,115,144,179],"significant":[98,118,147],"tumor":[99,139],"reduction":[100],"improved":[102],"survival":[103],"over":[104],"single-agent":[105],"treatment":[106],"murine":[109],"BRAFV600E":[110],"model.":[112],"The":[113],"increase":[119,148,163],"PD-L1+":[121],"neutrophils":[122],"monocytes":[124],"at":[125,153],"an":[126,134,162,172,277],"early":[127],"time":[128,156],"point":[129],"following":[130,252],"therapy":[131,198,253],"administration,":[132],"suggesting":[133],"inflammatory":[135],"switch":[136],"microenvironment.":[140],"Importantly,":[141],"cytotoxic":[150],"CD8+":[151],"cells":[152,238],"later":[155],"point,":[157],"was":[159],"accompanied":[160],"CD25+":[165],"Foxp3+":[166],"T-regulatory":[167],"(Treg)":[168],"cells.":[169],"Addition":[170],"anti-CD25":[173],"antibody":[174],"PLX4720/HSV1716":[177],"doublet":[178],"complete":[181],"eradication":[182],"tumors":[185],"vivo.":[187,240],"Current":[188],"efforts":[189],"focused":[191],"deciphering":[193],"T-cell":[194,231],"dynamics":[195,257],"during":[196],"this":[197],"using":[199],"technology,":[202],"Timer":[203,214],"cell":[205,263,327],"kinetics":[206],"activity":[208],"(Tocky).":[209],"Tocky":[210],"uses":[211],"fluorescent":[213],"protein":[215],"spontaneously":[217],"changes":[218],"its":[219],"emission":[220],"spectrum":[221],"from":[222],"blue":[223],"red,":[225],"reporting":[226],"real-time":[227,256],"receptor":[232],"Using":[241],"Tocky,":[242],"identifying":[245],"specific":[246],"subsets":[248],"stimulated":[251],"antigen":[259],"recognition":[260],"activation.":[264],"These":[265],"findings":[266],"form":[267],"basis":[269],"future":[271],"testing":[272],"drug-virus":[274],"combinations":[275],"effort":[278],"identify":[280],"potent":[281],"cytotoxic,":[282],"as":[283,285],"well":[284],"immuno-modulatory,":[286],"strategies":[287],"detailed":[290],"mechanism":[291],"action.":[293],"Citation":[294],"Format:":[295],"Galabina":[296],"Bozhanova,":[297],"Victoria":[298],"Jennings,":[299],"Malin":[300],"Pedersen,":[301],"Joan":[302],"Kyula,":[303],"Emmanuel":[304],"Patin,":[305],"Jehanne":[306],"Hassan,":[307],"Masahiro":[308],"Ono,":[309],"Kevin":[310],"Harrington,":[311],"Alan":[312],"Melcher.":[313],"Mutant":[314],"small":[316],"inhibition":[318],"enhances":[319],"immunotherapy":[323],"through":[324],"increased":[325],"recruitment":[328],"[abstract].":[333],"In:":[334],"Proceedings":[335],"Annual":[338],"Meeting":[339],"American":[342],"Association":[343],"for":[344],"Cancer":[345,357],"Research":[346],"2020;":[347],"2020":[348],"Apr":[349],"27-28":[350],"Jun":[352],"22-24.":[353],"Philadelphia":[354],"(PA):":[355],"AACR;":[356],"Res":[358],"2020;80(16":[359],"Suppl):Abstract":[360],"nr":[361],"3415.":[362]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}